Data from EMC - Curated by Toby Galbraith - Last updated 01 November 2016

Indication(s)

Abraxane monotherapy is indicated for the treatment of metastatic breast cancer in adult patients who have failed first-line treatment for metastatic disease and for whom standard, anthracycline containing therapy is not indicated.

Abraxane in combination with gemcitabine is indicated for the first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas.

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Bedwetting

Essential screening, diagnosis and best strategies to manage bedwetting

Visit Bedwetting

Fluid Management

Are you up-to-date with the latest evidence of effective procedures for fluid management?

Visit Fluid Management

More information

Category Value
Orphan designation No
Type POM
Marketing authorisation holder Celgene Europe Limited

Related Content